Home

TCG Crossover GP II reported a 7.2% stake in Monte Rosa Therapeutics GLUE · 4,427,705 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
7.2%
Last report
First report
Shares held
4,427,705 sh
Class
Common Stock, par value $0.0001 per share
Event date
25/10/10
Filed
25/10/17

First 5%+ report · 7.2% stake

Monte Rosa Therapeutics trades, last 26 weeks

What else happened in Monte Rosa Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/10~25/11/09

TCG Crossover GP II's other 5% stake reports

  • TCG Crossover GP II

    5% stakeAlx Oncology Holdings

    4.2% stake

    Filed 08/14

  • TCG Crossover GP II

    5% stakeFirst Tracks Biotherapeutics

    8.3% stake

    Filed 08/14

  • TCG Crossover GP II

    5% stakeFulcrum Therapeutics

    0% stake

    Filed 08/14

  • TCG Crossover GP II

    5% stakeLB Pharmaceuticals

    5% stake

    Filed 08/14

  • TCG Crossover GP II

    5% stakeTango Therapeutics

    7% stake

    Filed 08/14